Please find enclosed the Notice of Postal Ballot together with explanatory statement sent to the members of the Company.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sudarshan Pharma Industries has issued a Postal Ballot notice to members seeking approval for one special resolution: the appointment of Dr. Vijay Ojha (DIN: 02216129) as a Non-Executive Independent Director for a 5-year term from October 18, 2025 to October 17, 2030. Dr. Ojha holds a PhD from Central Drug Research Institute, Lucknow, and brings over 30 years of pharma industry experience with companies like Lupin, Sun Pharma, IPCA Laboratories, and Flavine Inc. USA, specialising in API and formulation development. Voting will be conducted electronically through NSDL, starting December 15, 2025 (9:00 AM) and ending January 13, 2026 (5:00 PM), with results announced on January 14, 2026. The cut-off date for eligibility is December 5, 2025. Mr. Vishal Manseta has been appointed as the Scrutinizer for the process.
This is a routine board-strengthening move that adds deep pharmaceutical R&D and commercialisation expertise to the board. No immediate material impact on stock price is expected; the appointment requires shareholder approval through postal ballot.